Freenome, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
FRNM Nasdaq 2836 www.freenome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Freenome, Inc.

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test - Aug 12th, 2026 7:00 am
Freenome (FRNM) Climbed, But What Is Driving Attention Now? - Aug 10th, 2026 9:19 pm
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook - Jul 31st, 2026 2:22 pm
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. - Jul 27th, 2026 6:00 am
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection - Jul 20th, 2026 2:01 pm